Prospective study of effecacy and safety of switch from oral medicine of tramadolto fentanyl sticking medicine (dyuroteppu MT patch on the 3rd) in lung cancer and malignant pleura mesothelioma with the pain - Prospective study of switch from oral medicine of tramadolto fentanyl sticking medicine in thoracic malignancy with the pain

Osaka Prefectural Medical Center for Respiratory and Allergic Diseases0 个研究点目标入组 15 人开始时间: 2011年5月19日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Patient who has hypersensitivity for opioid Patient who has previous history of opioid abuse Patient who has breath function trouble of chronic lung disorders etc. Defective asthmatic patient to control Patient who has serious depressed ventricular function Patient who has serious liver and renal dysfunction Patient who has increased intracranial pressure and impaired consciousness Patient who has skin disorder such as eczema and atopy in experimental drug sticking part Patient where generation of heat of 40 degree or more is admitted Patient who has pregnant woman, breast-feeding woman or possibility of pregnancy Patient who has scheduled patient or administering that administers pentazocine and Pius id receptor rivalry medicine of buprenorphine etc. within two days before it sticks it (The patient who executes the bronchoscope treatment excludes it). Patient whose age is less than 18 years old

发起方

Osaka Prefectural Medical Center for Respiratory and Allergic Diseases